{
  "id": "quantitative-pcr",
  "title": "Quantitative PCR",
  "lang": "en",
  "source_lang": "en",
  "summary": "Quantitative PCR measures nucleic acid abundance by tracking fluorescence during amplification, enabling sensitive analysis of genes, transcripts, and pathogens.",
  "category": "science",
  "subcategory": "biology",
  "type": "concept",
  "aliases": [
    "qPCR",
    "real-time PCR",
    "real-time quantitative PCR",
    "quantitative polymerase chain reaction"
  ],
  "generated_at": "2026-11-03",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/quantitative-pcr/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/quantitative-pcr/",
      "json": "https://aiwiki.page/zh/quantitative-pcr.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Quantitative PCR (qPCR) is a laboratory method that estimates the amount of a specific nucleic acid sequence by measuring its amplification during the polymerase chain reaction. Fluorescent signals are recorded as the reaction proceeds, allowing the initial abundance of a target to be inferred from the number of amplification cycles required to produce a detectable signal. Unlike conventional endpoint PCR, which usually examines products after amplification has finished, qPCR uses measurements made while product accumulation still retains a predictable relationship to starting quantity.\n\nThe method is widely used in molecular biology, biotechnology, environmental analysis, and clinical laboratories. It can quantify DNA directly or measure RNA after conversion to complementary DNA by reverse transcription. The latter approach, reverse-transcription quantitative PCR, is central to studies of gene expression and the detection of RNA viruses. Depending on its calibration and experimental design, qPCR can report target copies, concentrations, or abundance relative to another sample or sequence.\n\nIts sensitivity does not make it a direct molecular counting method. The relationship between fluorescence and starting material depends on amplification efficiency, sample preparation, assay specificity, and data analysis. Understanding these dependencies is essential to interpreting both numerical measurements and qualitative positive or negative results."
    },
    {
      "heading": "Historical development and terminology",
      "text": "The development of qPCR followed the introduction of PCR in the 1980s. Conventional PCR made it possible to amplify a selected DNA region through repeated cycles of strand separation, primer binding, and enzymatic extension. Early quantitative approaches often compared endpoint products using gel electrophoresis or introduced a competitor sequence in a known amount. These methods faced an important limitation: reactions with substantially different starting quantities could yield similar final product amounts because amplification eventually slowed and reached a plateau.\n\nA major step toward real-time measurement came from the use of fluorescent reporters that could be observed without opening reaction tubes. In 1992, Russell Higuchi and colleagues described monitoring amplification through the increasing fluorescence of ethidium bromide associated with double-stranded DNA. Their subsequent work in 1993 demonstrated the kinetic analysis of PCR amplification. Measuring the development of a signal over successive cycles provided a way to estimate starting quantity before plateau effects dominated.\n\nSequence-specific fluorescence developed along a complementary path. In 1991, Pamela Holland and colleagues described a PCR detection approach that exploited the 5′ nuclease activity of a thermostable DNA polymerase to cleave a hybridized probe. Fluorogenic reporter–quencher probes subsequently made this mechanism suitable for closed-tube fluorescence monitoring. Work by Kenneth Livak and colleagues in 1995 helped establish the dual-labeled probe format associated with TaqMan assays. Commercial instruments integrating thermal cycling, excitation light, fluorescence detection, and analysis software made these approaches broadly accessible during the 1990s.\n\n“Real-time PCR” describes when amplification is monitored; “quantitative PCR” describes a measurement purpose. The terms are often used interchangeably, although a real-time assay may be interpreted only as target detected or not detected. Conversely, some older quantitative PCR methods did not use real-time fluorescence. The abbreviation qPCR generally denotes quantitative real-time PCR in contemporary usage.\n\nReverse transcription introduces another terminological distinction. “RT-PCR” traditionally means reverse-transcription PCR, not real-time PCR. The more explicit abbreviation RT-qPCR denotes reverse transcription followed by quantitative PCR, whether the two reactions occur in one tube or in separate stages. Reverse transcription is necessary for RNA targets because the amplification stage uses DNA as its template.\n\nThe expansion of qPCR also exposed problems in reproducibility and reporting. The Minimum Information for Publication of Quantitative Real-Time PCR Experiments, or MIQE guidelines, published by Stephen Bustin and colleagues in 2009, established a framework for documenting sample quality, assay design, controls, efficiency, normalization, and analysis. These recommendations helped shift attention from instrument-generated numbers toward the evidence needed to support their biological interpretation."
    },
    {
      "heading": "Amplification kinetics and fluorescence measurement",
      "text": "A qPCR reaction contains a template, two sequence-specific primers, a thermostable polymerase, deoxyribonucleotides, an appropriate buffer, magnesium ions, and a fluorescent detection system. Thermal cycling separates DNA strands, allows primers to anneal to complementary sequences, and permits polymerase-mediated extension. Many assays use an initial activation or denaturation step followed by approximately 35–45 cycles, although temperatures, cycle numbers, and timing depend on the chemistry and intended application.\n\nIn an idealized exponential phase, product abundance follows\n\n\\[N_n=N_0(1+E)^n,\\]\n\nwhere \\(N_0\\) is the initial number of amplifiable target molecules, \\(N_n\\) is the amount after \\(n\\) cycles, and \\(E\\) is amplification efficiency expressed as a fraction. At \\(E=1\\), corresponding to 100% efficiency, the target doubles each cycle. This model is an approximation: efficiency may vary with cycle number, template composition, inhibition, and reagent availability.\n\nAn amplification curve commonly contains an early baseline region, a rising region, and a plateau. Initially, product-associated fluorescence is too small to distinguish reliably from background. As amplification proceeds, fluorescence rises above that background. Later, amplification slows because the reaction environment changes, including depletion or reduced availability of reagents, accumulation of products, and competition between primer binding and product reannealing. Plateau fluorescence therefore does not provide a dependable measure of starting abundance.\n\nThe principal reported cycle coordinate is the quantification cycle, \\(C_q\\). Instrument software may instead use the terms threshold cycle, \\(C_t\\), or crossing point, \\(C_p\\). A threshold-based method determines where the amplification curve crosses a selected fluorescence level. Other algorithms use curve shape, derivatives, or fitted models. These different approaches can produce different numerical values from the same fluorescence record, making the analysis method part of the measurement procedure.\n\nFor a fixed threshold and constant efficiency,\n\n\\[C_q=\\frac{\\ln(N_{\\mathrm{threshold}}/N_0)}{\\ln(1+E)}.\\]\n\nThus, a larger starting quantity produces an earlier crossing. At 100% efficiency, a tenfold difference in starting target corresponds to approximately 3.32 cycles, while a twofold difference corresponds to one cycle. These relationships apply only when the compared reactions have sufficiently similar amplification behavior and compatible fluorescence analysis.\n\nA real-time instrument combines a thermal block or another heating system with excitation sources, optical filters, and fluorescence detectors. Measurements are usually made at a defined point during each cycle so that signals are compared at similar temperatures. Multichannel instruments distinguish several fluorescent reporters and can monitor multiple targets in one reaction. Thermal uniformity, optical calibration, evaporation control, and reaction-volume consistency all affect comparability across wells."
    },
    {
      "heading": "Fluorescent dyes, probes, and multiplex detection",
      "text": "The simplest common detection chemistry uses a fluorescent dye whose signal increases strongly when associated with double-stranded DNA. SYBR Green I is a widely used example. As amplification produces more double-stranded product, fluorescence increases. Dye-based assays require only the target-specific primers in addition to the general reaction reagents, making them flexible and comparatively inexpensive when many different targets are being investigated.\n\nThe principal limitation is that the dye does not identify the amplified sequence. Desired products, unintended amplicons, and primer dimers can all contribute fluorescence. A primer dimer is a short amplification product generated when primers interact and are extended rather than amplifying the intended template. Such products can be particularly important when the true target is scarce.\n\nA post-amplification melting-curve analysis helps characterize dye-detected products. The instrument gradually raises the temperature and records the decrease in fluorescence as double-stranded DNA dissociates. Plotting the negative derivative of fluorescence against temperature produces melting peaks. A single dominant peak is consistent with a predominant product, but it does not by itself establish sequence identity: different products can have similar melting behavior, and minor products may remain unresolved.\n\nHydrolysis probes provide an additional level of sequence recognition. A typical probe contains a fluorescent reporter and a quencher and binds within the region between the two primers. When the probe is intact, the quencher suppresses reporter emission. During extension, the polymerase’s 5′ nuclease activity cleaves the bound probe, separating reporter and quencher and increasing detectable fluorescence. Signal generation therefore depends on both primer-directed amplification and probe hybridization.\n\nOther probe designs use different physical mechanisms. Molecular beacons form a stem–loop structure that brings reporter and quencher together until target binding opens the structure. Paired hybridization probes can produce fluorescence through energy transfer when both bind adjacent sites on an amplicon. These chemistries differ in probe design constraints, temperature dependence, suitability for melting analysis, and the extent to which mismatches affect signal generation.\n\nMultiplex PCR combines several primer pairs and distinguishable detection systems in one reaction. It can measure multiple pathogen targets, a target plus an internal control, or alternative sequence variants. The number of usable channels is limited not only by instrument optics but also by chemical interactions. Primers may form unintended products, abundant targets may compete with rare targets, and overlapping emission spectra require compensation or other optical corrections.\n\nProbe-based detection does not eliminate all specificity problems. A target variant can alter primer or probe binding and reduce detection. Conversely, a closely related sequence may retain sufficient complementarity to generate a signal. Specificity therefore depends on the complete assay—the selected genomic region, oligonucleotide sequences, reaction conditions, and interpretation rules—not simply on the presence of a probe."
    },
    {
      "heading": "Sample preparation, assay design, and reverse transcription",
      "text": "The quantity entering a qPCR tube is only a fraction of the material originally sampled. Collection, transport, storage, extraction, elution, and transfer can all change the number of amplifiable molecules. For this reason, qPCR measurements are inseparable from their preanalytical history. A highly reproducible amplification reaction cannot recover a target that was degraded or lost before the reaction began.\n\nExtraction must separate nucleic acids from substances that interfere with amplification. Relevant inhibitors include heme in blood, complex organic substances in soil, and compounds carried over from extraction reagents. Inhibition can act by interfering with polymerase activity, changing magnesium availability, or affecting template accessibility. Diluting an extract may reduce inhibition, but it also reduces target concentration. Consequently, a later or absent signal can reflect low target abundance, inhibition, or both.\n\nAssay design starts with a defined sequence and an explicit biological question. Primers must recognize the intended target while avoiding related sequences and problematic self-complementarity. Amplicons of roughly 70–200 base pairs are common because short products are generally compatible with efficient amplification and partially fragmented templates. This is a practical range rather than a universal rule; longer products may be appropriate for particular assays.\n\nFor expression measurements, the selected region determines which transcripts are detected. Primers in exons shared by several isoforms measure a different biological quantity from primers specific to one splice junction. Alternative splicing, paralogous genes, pseudogenes, and genomic DNA contamination can complicate interpretation. A primer spanning an exon–exon junction, or a primer pair separated by a large genomic intron, can help distinguish complementary DNA from genomic DNA, although such designs are not possible for every target.\n\nRNA analysis adds a reverse-transcription step. Reverse transcriptase converts RNA into complementary DNA using gene-specific primers, random primers, oligo(dT), or combinations of these. Oligo(dT) preferentially targets polyadenylated RNA, including most eukaryotic messenger RNA, whereas random primers can also copy nonpolyadenylated RNA. RNA structure, fragmentation, primer choice, and enzyme properties influence conversion yield. An accurately quantified DNA standard does not automatically account for these sources of variation.\n\nIn one-step RT-qPCR, reverse transcription and amplification occur sequentially in the same tube. In two-step RT-qPCR, complementary DNA is generated separately and aliquots can be used for multiple assays. The two-step format offers flexibility, while the closed one-step format reduces transfers and can simplify standardized testing. Neither format makes RNA conversion quantitatively complete.\n\nSample quality measurements therefore complement, rather than replace, functional controls. Absorbance ratios describe aspects of purity, and electrophoretic methods can characterize RNA integrity, but neither establishes the amplifiability of every target. For fragmented material, including formalin-fixed tissue, the location and length of the amplicon can strongly influence the result."
    },
    {
      "heading": "Absolute quantification and calibration",
      "text": "Absolute quantification estimates target abundance in units such as copies per reaction, copies per microlitre, or copies per original sample volume. The conventional approach compares unknown samples with a dilution series containing assigned amounts of the target. These calibrators generate a relationship between \\(C_q\\) and the logarithm of starting quantity:\n\n\\[C_q=m\\log_{10}(N_0)+b,\\]\n\nwhere \\(m\\) is the slope and \\(b\\) the intercept. An unknown quantity is calculated by inverting the fitted relationship:\n\n\\[N_0=10^{(C_q-b)/m}.\\]\n\nThe slope also provides an estimate of amplification efficiency:\n\n\\[E=10^{-1/m}-1.\\]\n\nA slope near \\(-3.32\\) corresponds to 100% efficiency. Efficiencies around 90–110% are commonly used as an initial assay-evaluation range, but an acceptable range depends on the method and purpose. An apparently excessive efficiency can indicate inhibition that changes across dilutions, nonspecific amplification, dilution errors, or inappropriate fluorescence analysis. It does not ordinarily mean that the intended target is genuinely multiplying by more than twofold per cycle.\n\nCalibration materials include plasmids, purified amplification products, synthetic DNA, RNA transcripts, and biological materials with assigned target concentrations. Each has limitations. Supercoiled plasmids can amplify differently from linear DNA. DNA calibrators bypass reverse transcription in an RNA assay. Purified target molecules added directly to the reaction do not represent losses during extraction from a biological matrix.\n\nWhen a DNA standard is assigned by mass, copy number can be calculated from molecular mass and the Avogadro constant. For double-stranded DNA of length \\(L\\) base pairs and mass \\(m_{\\mathrm{DNA}}\\),\n\n\\[N\\approx\\frac{m_{\\mathrm{DNA}}N_{\\mathrm A}}{660L},\\]\n\nwith mass expressed in grams and 660 grams per mole used as an approximate average molar mass per base pair. This conversion inherits uncertainty from mass measurement, molecular length, purity, and the molecular-mass approximation. In a plasmid standard, \\(L\\) includes the complete plasmid, not merely the inserted target.\n\nCalibration must also match the quantity being reported. Copies per reaction become copies per millilitre only after accounting for input volume, extraction and elution volumes, dilutions, and the fraction of extract tested. Recovery corrections require additional evidence. A precise result at the reaction level may be much less certain when extrapolated to the original specimen.\n\nMetrological traceability concerns the documented chain connecting a measurement to a reference through calibrations with stated uncertainties. Some clinical assays use international standards and report international units rather than molecular copies. These units improve comparability for a defined material and assay context; they are not necessarily interchangeable with genome counts. Differences in reference materials, extraction procedures, target regions, and calibration models can persist between laboratories even when each laboratory obtains internally consistent results."
    },
    {
      "heading": "Relative quantification and gene-expression normalization",
      "text": "Relative quantification compares the abundance of a target between samples without necessarily assigning a copy number. Its most familiar use is measuring changes in transcript abundance between experimental conditions. A target signal is normalized to one or more reference genes, and the normalized value is then compared with a calibrator sample, such as an untreated condition.\n\nThe widely used comparative-cycle calculation is\n\n\\[\\Delta C_q=C_{q,\\mathrm{target}}-C_{q,\\mathrm{reference}},\\]\n\nfollowed by\n\n\\[\\Delta\\Delta C_q=\\Delta C_{q,\\mathrm{sample}}-\\Delta C_{q,\\mathrm{calibrator}}.\\]\n\nIf both assays have approximately 100% and sufficiently similar amplification efficiencies, relative abundance is\n\n\\[R=2^{-\\Delta\\Delta C_q}.\\]\n\nUnder these assumptions, a \\(\\Delta\\Delta C_q\\) of \\(-1\\) corresponds to a twofold increase, whereas a value of \\(1\\) corresponds to a twofold decrease. Kenneth Livak and Thomas Schmittgen described this method in a widely used 2001 publication.\n\nThe efficiency assumptions matter because cycle differences are logarithmic, not direct concentration differences. When target and reference assays amplify at different rates, an efficiency-corrected model is more appropriate. One form, associated with Michael Pfaffl’s 2001 work, is\n\n\\[R= \\frac{(1+E_t)^{C_{q,t,\\mathrm{calibrator}}-C_{q,t,\\mathrm{sample}}}} {(1+E_r)^{C_{q,r,\\mathrm{calibrator}}-C_{q,r,\\mathrm{sample}}}},\\]\n\nwhere \\(E_t\\) and \\(E_r\\) are the efficiencies of the target and reference assays. This model still requires reliable efficiency estimates and reference measurements.\n\nA reference gene is not valid merely because it performs a basic cellular function. Commonly used reference genes such as ACTB and GAPDH can vary with tissue type, differentiation, metabolic state, or experimental treatment. Reference stability must be evaluated in the biological setting being studied. Using several independently selected reference genes can reduce dependence on a single unstable transcript. Their quantities are commonly combined using a geometric mean.\n\nNormalization defines the meaning of the result. Equal total RNA input yields transcript abundance relative to the RNA pool, not necessarily transcripts per cell. A treatment that changes cell size, total RNA content, or the proportion of cell types can change the interpretation. Similarly, reference genes that remain stable per unit RNA may not remain stable per cell. External spike-ins can monitor selected technical processes, but they do not automatically correct for biological differences in sample composition.\n\nTechnical replicate reactions estimate variability introduced by dispensing, amplification, and detection. Biological replicates capture variation among independently sampled organisms, cultures, or specimens. Repeating the same extract in many wells cannot substitute for independent biological replication. Because fold changes are multiplicative and often asymmetric, statistical analysis commonly uses cycle differences or logarithmically transformed quantities rather than treating raw fold changes as normally distributed.\n\nRT-qPCR measures steady-state RNA abundance, not transcription rate alone. A change can reflect altered transcription, RNA processing, or degradation. It also does not necessarily predict protein abundance, which depends on translation and protein turnover."
    },
    {
      "heading": "Analytical validation, controls, and uncertainty",
      "text": "A qPCR assay is characterized by more than its standard-curve slope. Important properties include analytical specificity, sensitivity, linearity, precision, working range, robustness, and measurement uncertainty. These properties must be established for the relevant sample types and intended interpretation. An assay validated for purified DNA is not automatically validated for blood, soil, tissue, or wastewater.\n\nThe limit of detection is the lowest concentration at which the target can be detected with a specified probability under stated conditions, often 95%. The limit of quantification is the lowest concentration that can be measured with predefined precision and accuracy. These limits are different: an assay may detect a target intermittently at concentrations too low for reliable numerical quantification.\n\nAt low abundance, molecular sampling imposes a fundamental constraint. If target molecules are randomly distributed and the mean number entering a reaction is \\(\\lambda\\), the probability of receiving no target follows the zero term of a Poisson distribution:\n\n\\[P(0)=e^{-\\lambda}.\\]\n\nAt an average of one copy per reaction, approximately 37% of reactions contain no target. At an average of three copies, approximately 5% contain none. These figures assume ideal random sampling and do not include extraction losses or amplification failure. A nominally low-copy sample can therefore produce a mixture of positive and negative wells without any contradiction.\n\nControls distinguish different causes of failure or false signal. A no-template control tests for contamination in reaction components and can reveal primer-dimer formation in dye assays. An extraction blank passes through sample processing and can reveal contamination introduced before amplification. A positive amplification control demonstrates that the assay can detect its target under the run conditions.\n\nAn internal amplification control tests whether a particular reaction environment supports amplification. An exogenous process control added before extraction can additionally monitor aspects of recovery, although it may not behave exactly like the native target. In RT-qPCR, a no-reverse-transcription control tests for amplifiable DNA that would otherwise be mistaken for RNA-derived signal. No single control covers all failure modes.\n\nCarryover contamination is especially important because PCR creates large quantities of its own target. Closed-tube detection reduces the need to handle amplified products. Workflows may also use deoxyuridine triphosphate and uracil-DNA glycosylase to degrade susceptible products from earlier reactions before amplification. This system does not remove every possible contaminant, including target DNA lacking uracil.\n\nMeasurement uncertainty accumulates across sampling, extraction, dilution, calibration, amplification, and analysis. A high standard-curve coefficient of determination does not establish specificity, accurate calibrator assignment, or freedom from bias. Likewise, a very small spread among replicate \\(C_q\\) values does not prove that the reported biological quantity is accurate. Validation requires evidence addressing the complete measurement process rather than a single favorable instrument statistic."
    },
    {
      "heading": "Biological, clinical, and environmental applications",
      "text": "Gene-expression analysis is one of qPCR’s most established applications. Investigators use RT-qPCR to measure selected transcripts during development, differentiation, stress responses, and experimental perturbations. Its targeted nature allows sensitive measurement of a small number of predefined sequences and makes it useful for examining findings from broader methods such as RNA sequencing. Agreement between platforms depends on transcript definitions, normalization, and whether the methods distinguish the same isoforms.\n\nDNA-based qPCR can estimate gene copy number by comparing a target locus with a reference locus. Applications include analysis of deletions, duplications, transgene abundance, and mitochondrial DNA relative to nuclear DNA. Interpretation depends on assumptions about ploidy, sample composition, and reference stability. In a mixed sample, an average copy-number change may reflect either a large change in a minority of cells or a smaller change across most cells.\n\nIn clinical microbiology, qPCR detects selected bacterial, viral, fungal, and parasitic sequences. Calibrated assays can measure viral nucleic acid concentrations, including those used in monitoring infections such as HIV, hepatitis B, and cytomegalovirus. RT-qPCR was also a major laboratory method for detecting SARS-CoV-2 RNA during the COVID-19 pandemic. These applications use validated combinations of specimen type, extraction procedure, target sequence, controls, and interpretation criteria.\n\nNucleic acid detection is not identical to demonstrating viable organisms or infectious particles. DNA or RNA can persist after biological activity has ceased. Similarly, the measured abundance of one genomic region is not automatically the number of intact genomes, because samples may contain fragmented molecules, free nucleic acids, or incomplete viral material. Clinical meaning therefore depends on the organism, specimen, timing, and assay.\n\nIn oncology, qPCR and RT-qPCR can detect selected sequence variants or quantify disease-associated transcripts. BCR::ABL1 transcript measurement in chronic myeloid leukemia is a prominent example in which standardized reporting frameworks support comparisons over time. Quantitative results in such settings depend on assay-specific calibration and validated reference systems, rather than on a universal conversion from \\(C_q\\) to disease burden.\n\nEnvironmental applications include measuring microbial genes in water, soil, sediments, and wastewater. Targets can indicate fecal contamination, antimicrobial resistance, or organisms involved in biogeochemical processes. Wastewater surveillance measures pathogen-associated nucleic acids in pooled community waste streams, but concentrations are affected by flow, degradation, sampling, concentration procedures, and extraction recovery.\n\nFood and agricultural laboratories use qPCR to detect pathogens, identify species-specific ingredients, and characterize genetically modified material. In these settings, DNA abundance must be distinguished from ingredient mass: genome size, ploidy, tissue type, and processing can alter the relationship. Across applications, qPCR is most informative when the reported quantity is explicitly tied to the biological entity and sampling process it represents."
    },
    {
      "heading": "Interpretation, reporting, and comparison with digital PCR",
      "text": "A \\(C_q\\) value is an intermediate measurement, not a universal concentration scale. It depends on the target, reaction chemistry, fluorescence threshold, instrument, and sample processing. Two assays can produce different cycle values from the same number of target molecules. Conversely, identical cycle values from different assays need not represent identical concentrations. Meaningful cross-laboratory comparison requires compatible calibration and defined reporting units.\n\nLate amplification deserves particular care because it may arise from very low target abundance, contamination, nonspecific products, or unstable curve analysis. There is no universal cycle number beyond which every result is invalid or below which every result is meaningful. Interpretation thresholds are assay-specific and depend on validation data, controls, replicate behavior, and the purpose of testing. A missing crossing is also ambiguous unless extraction performance and inhibition have been assessed.\n\nA negative result means that the target was not detected in the tested portion under the assay conditions. It does not establish complete absence from the original specimen or organism. Sampling variability, low abundance, target degradation, inhibitors, and sequence mismatches can all contribute to nondetection. This distinction is especially important when the sampled material is heterogeneous or when only a small fraction of an extract enters the reaction.\n\nTransparent reporting includes the sample source and handling, extraction method, nucleic acid input, primer and probe information, reaction conditions, instrument, analysis method, calibration model, efficiency, controls, and normalization strategy. Replicate structure and rules for excluding or classifying results also affect reproducibility. Raw amplification data and clearly described processing methods make it easier to distinguish a biological finding from an artifact of threshold selection or curve handling.\n\nDigital PCR provides a related but distinct measurement strategy. It divides a sample among many small partitions and classifies them as positive or negative after amplification. If \\(p\\) is the positive fraction and partitions receive molecules randomly, mean occupancy is estimated as\n\n\\[\\lambda=-\\ln(1-p).\\]\n\nConcentration is then derived from occupancy and partition volume. Digital PCR therefore estimates abundance through partition counting and a statistical model rather than through a calibration curve relating cycle position to quantity.\n\nDigital PCR can be valuable for assigning reference-material concentrations, measuring small copy-number differences, and detecting rare variants in suitable assays. It remains affected by molecular accessibility, inhibition, partition volume, threshold classification, and sampling uncertainty. RNA measurements still require reverse transcription, with its associated variability. Its useful concentration range also depends on partition number and occupancy, often making dilution necessary.\n\nqPCR remains well suited to rapid, high-throughput measurement across broad concentration ranges with established instruments and workflows. Digital PCR, sequencing, and other nucleic acid methods answer overlapping but different questions. The choice between them depends on whether the principal requirement is targeted quantification, molecular counting, sequence discovery, variant characterization, or measurement of many targets simultaneously."
    }
  ],
  "links": [
    "polymerase-chain-reaction",
    "molecular-biology",
    "dna",
    "rna",
    "gene-expression",
    "gel-electrophoresis",
    "dna-polymerase",
    "alternative-splicing",
    "reverse-transcriptase",
    "messenger-rna",
    "plasmid",
    "avogadro-constant",
    "calibration",
    "metrological-traceability",
    "cell",
    "transcription-biology",
    "measurement-uncertainty",
    "poisson-distribution",
    "gene",
    "bacteria",
    "digital-pcr"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}